Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Leukemia·2016
Same author

Fatal tracheal aspergillosis during rituximab combined chemotherapy for diffuse large B-cell lymphoma that developed after lung transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2015
Same author

Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.

The pharmacogenomics journal·2014
Same author

The role of an uncommon type of oral streptococcus sanguis in the etiology of behcet's disease.

Environmental health and preventive medicine·2011
Same author

Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program.

Bone marrow transplantation·2010
Same author

Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.

Leukemia·2009

Related Experiment Video

Updated: Jun 30, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Deafness in cryoglobulinemia

Y Nomura, M Tsuchida, S Mori

    The Annals of Otology, Rhinology, and Laryngology
    |May 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    This report details the first known examination of inner ear structures in a patient with cryoglobulinemia, a condition where abnormal proteins in the blood thicken in cold temperatures. The patient experienced severe hearing loss and tinnitus. Microscopic analysis revealed significant damage to the cochlea and inner ear canals, likely caused by poor blood flow. These findings suggest that cryoglobulinemia can directly damage the auditory system.

    Keywords:
    temporal bone pathologycochlear atrophyvestibular ossificationinner ear disease

    Frequently Asked Questions

    More Related Videos

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
    07:45

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

    Published on: October 21, 2014

    Immunolabelling Myofiber Degeneration in Muscle Biopsies
    06:37

    Immunolabelling Myofiber Degeneration in Muscle Biopsies

    Published on: December 5, 2019

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    Granulocyte-dependent Autoantibody-induced Skin Blistering
    12:23

    Granulocyte-dependent Autoantibody-induced Skin Blistering

    Published on: October 12, 2012

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
    07:45

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

    Published on: October 21, 2014

    Immunolabelling Myofiber Degeneration in Muscle Biopsies
    06:37

    Immunolabelling Myofiber Degeneration in Muscle Biopsies

    Published on: December 5, 2019

    Area of Science:

    • Otolaryngology research within essential cryoglobulinemia pathology
    • Clinical audiology and temporal bone histopathology

    Background:

    No prior work had resolved the specific anatomical damage within the inner ear caused by systemic cryoglobulinemia. It was already known that this condition involves abnormal blood proteins that precipitate in cold temperatures. Patients often report skin lesions and vascular issues during winter months. However, the connection between these vascular disturbances and auditory impairment remained poorly understood. Researchers lacked direct evidence from human temporal bone specimens to confirm the underlying pathology. This gap motivated a detailed histopathological investigation of a patient who suffered from progressive hearing loss. That uncertainty drove the need to examine the cochlear and vestibular structures post-mortem. No previous studies had documented these specific inner ear changes in the context of this rare disorder.

    Purpose Of The Study:

    The study aimed to document the histopathological changes in the temporal bone of a patient with essential cryoglobulinemia. Researchers sought to understand the physical basis for the progressive hearing loss and tinnitus reported by the patient. This investigation addressed the lack of anatomical data regarding how this systemic protein disorder affects the auditory system. The authors intended to correlate clinical symptoms with specific microscopic damage found in the inner ear. They aimed to determine if circulatory disturbances were responsible for the observed structural degradation. By examining the cochlea and vestibule, the team hoped to clarify the extent of tissue damage. This work was motivated by the patient's history of purpura and severe winter-related vascular issues. The researchers aimed to provide the first known report of such temporal bone findings in the medical literature.

    Main Methods:

    The review approach involved a detailed histopathological analysis of the left temporal bone from a deceased female patient. Investigators performed a microscopic evaluation of the cochlear and vestibular anatomy to document structural changes. They assessed the condition of the organ of Corti and the stria vascularis throughout the cochlear turns. The team examined the tectorial membrane for signs of drooping or encapsulation. Researchers inspected the scala media for the presence of eosinophilic precipitate near the Reissner membrane. They evaluated the status of spiral ganglion cells to determine if neural components remained intact. The team documented areas of fibrosis and ossification within the scala tympani and the basal turn. Finally, they scrutinized the semicircular canals and vestibule for signs of fusion and abnormal fluid-filled cysts.

    Main Results:

    The strongest finding revealed that the organ of Corti was either entirely absent or reduced to a mound. The stria vascularis displayed atrophy throughout the entire length of the cochlea. Eosinophilic precipitate appeared in the scala media where the Reissner membrane exhibited bulging. The spiral ganglion cells remained well preserved despite the extensive damage to surrounding tissues. Fibrosis and ossification were intermingled within the scala tympani, particularly in the lower basal turn. Ossification reached its most marked levels near the basal end of the cochlea. The semicircular canals and vestibule were almost completely ossified and fused with the surrounding bone. A small, cyst-like structure containing eosinophilic fluid was identified within the vestibule.

    Conclusions:

    The authors propose that the observed deafness resulted from circulatory disturbances linked to the underlying systemic condition. This investigation represents the first documented case of temporal bone pathology in a patient with this specific protein disorder. The findings suggest that vascular impairment leads to significant structural degradation within the cochlea and vestibular system. Fibrosis and ossification patterns indicate long-term damage to the inner ear environment. The authors emphasize that the preservation of spiral ganglion cells contrasts with the severe atrophy seen in other cochlear structures. These results provide a potential explanation for the progressive hearing loss reported by the patient. The study highlights the importance of considering vascular-related auditory damage in patients with cryoglobulinemia. Future clinical assessments might benefit from recognizing these potential inner ear complications.

    The researchers propose that the deafness stemmed from circulatory disturbances caused by cryoglobulinemia. This systemic condition leads to protein precipitation, which impairs blood flow to the inner ear, resulting in the observed atrophy and ossification of cochlear and vestibular structures.

    The study utilized histopathological examination of the temporal bone. This approach allowed for the microscopic assessment of the organ of Corti, stria vascularis, and the vestibular system to identify structural abnormalities.

    The authors note that the semicircular canals and vestibule were almost totally ossified and fused with surrounding bone. This extensive ossification was necessary to explain the profound vestibular dysfunction and the total deafness observed in the patient.

    The study relied on post-mortem histopathological data. This component provided the necessary evidence to correlate the patient's clinical history of progressive hearing loss with the physical damage found in the temporal bone.

    The researchers measured the state of the organ of Corti, which was either missing or present as a mound. Additionally, they observed eosinophilic precipitate in the scala media, indicating abnormal fluid composition within the cochlea.

    The authors suggest that their findings indicate a direct link between systemic circulatory issues and auditory impairment. They propose that this case serves as a reference for future clinical evaluations of patients with similar protein-related vascular disorders.